nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Isopropamide—Benzphetamine—obesity	0.627	1	CrCrCtD
Propantheline—Anhidrosis—Topiramate—obesity	0.0106	0.0465	CcSEcCtD
Propantheline—Urinary hesitation—Phenylpropanolamine—obesity	0.0104	0.0454	CcSEcCtD
Propantheline—Hypohidrosis—Topiramate—obesity	0.00578	0.0253	CcSEcCtD
Propantheline—Sweating decreased—Topiramate—obesity	0.00578	0.0253	CcSEcCtD
Propantheline—Mydriasis—Diethylpropion—obesity	0.00445	0.0195	CcSEcCtD
Propantheline—Erectile dysfunction—Methamphetamine—obesity	0.00328	0.0143	CcSEcCtD
Propantheline—Drowsiness—Phenylpropanolamine—obesity	0.00238	0.0104	CcSEcCtD
Propantheline—Erectile dysfunction—Phentermine—obesity	0.00236	0.0103	CcSEcCtD
Propantheline—Flushing—Phendimetrazine—obesity	0.00233	0.0102	CcSEcCtD
Propantheline—Palpitations—Methamphetamine—obesity	0.00219	0.00959	CcSEcCtD
Propantheline—Dermatitis atopic—Bupropion—obesity	0.00213	0.00929	CcSEcCtD
Propantheline—Palpitations—Benzphetamine—obesity	0.00212	0.00925	CcSEcCtD
Propantheline—Vision blurred—Phendimetrazine—obesity	0.00206	0.00899	CcSEcCtD
Propantheline—Erectile dysfunction—Diethylpropion—obesity	0.00205	0.00897	CcSEcCtD
Propantheline—Flushing—Phenylpropanolamine—obesity	0.00199	0.00869	CcSEcCtD
Propantheline—Drowsiness—Diethylpropion—obesity	0.00199	0.00868	CcSEcCtD
Propantheline—Tachycardia—Methamphetamine—obesity	0.00198	0.00865	CcSEcCtD
Propantheline—Mydriasis—Bupropion—obesity	0.00197	0.00863	CcSEcCtD
Propantheline—Erectile dysfunction—Cimetidine—obesity	0.00195	0.00853	CcSEcCtD
Propantheline—Palpitations—Phendimetrazine—obesity	0.00193	0.00843	CcSEcCtD
Propantheline—Tachycardia—Benzphetamine—obesity	0.00191	0.00834	CcSEcCtD
Propantheline—Drowsiness—Cimetidine—obesity	0.00189	0.00826	CcSEcCtD
Propantheline—Insomnia—Methamphetamine—obesity	0.00183	0.00801	CcSEcCtD
Propantheline—Tension—Phenylpropanolamine—obesity	0.00183	0.008	CcSEcCtD
Propantheline—Nervousness—Phenylpropanolamine—obesity	0.00181	0.00792	CcSEcCtD
Propantheline—Insomnia—Benzphetamine—obesity	0.00177	0.00773	CcSEcCtD
Propantheline—Vision blurred—Phenylpropanolamine—obesity	0.00176	0.00768	CcSEcCtD
Propantheline—Salivary hypersecretion—Sibutramine—obesity	0.00175	0.00766	CcSEcCtD
Propantheline—Tension—Phentermine—obesity	0.00175	0.00765	CcSEcCtD
Propantheline—Accommodation disorder—Topiramate—obesity	0.00174	0.00763	CcSEcCtD
Propantheline—Tachycardia—Phendimetrazine—obesity	0.00174	0.0076	CcSEcCtD
Propantheline—Constipation—Methamphetamine—obesity	0.00173	0.00758	CcSEcCtD
Propantheline—Nervousness—Phentermine—obesity	0.00173	0.00758	CcSEcCtD
Propantheline—Insomnia—Phendimetrazine—obesity	0.00161	0.00704	CcSEcCtD
Propantheline—Urticaria—Methamphetamine—obesity	0.00161	0.00704	CcSEcCtD
Propantheline—CHRM3—muscle of abdomen—obesity	0.00158	0.591	CbGeAlD
Propantheline—Palpitations—Phentermine—obesity	0.00158	0.00689	CcSEcCtD
Propantheline—Urticaria—Benzphetamine—obesity	0.00155	0.00679	CcSEcCtD
Propantheline—Confusional state—Phenylpropanolamine—obesity	0.00153	0.00671	CcSEcCtD
Propantheline—Salivary hypersecretion—Bupropion—obesity	0.00153	0.00668	CcSEcCtD
Propantheline—Constipation—Phendimetrazine—obesity	0.00152	0.00666	CcSEcCtD
Propantheline—Tension—Diethylpropion—obesity	0.00152	0.00666	CcSEcCtD
Propantheline—Nervousness—Diethylpropion—obesity	0.00151	0.00659	CcSEcCtD
Propantheline—Hypersensitivity—Methamphetamine—obesity	0.00149	0.00653	CcSEcCtD
Propantheline—Dry mouth—Phentermine—obesity	0.00148	0.00649	CcSEcCtD
Propantheline—Tachycardia—Phenylpropanolamine—obesity	0.00148	0.00649	CcSEcCtD
Propantheline—Vision blurred—Diethylpropion—obesity	0.00146	0.00639	CcSEcCtD
Propantheline—Hypersensitivity—Benzphetamine—obesity	0.00144	0.00629	CcSEcCtD
Propantheline—Thirst—Orlistat—obesity	0.00142	0.00622	CcSEcCtD
Propantheline—Tachycardia—Phentermine—obesity	0.00142	0.00621	CcSEcCtD
Propantheline—Thirst—Sibutramine—obesity	0.00138	0.00602	CcSEcCtD
Propantheline—Insomnia—Phenylpropanolamine—obesity	0.00138	0.00602	CcSEcCtD
Propantheline—Palpitations—Diethylpropion—obesity	0.00137	0.006	CcSEcCtD
Propantheline—Dermatitis atopic—Topiramate—obesity	0.00135	0.00592	CcSEcCtD
Propantheline—Somnolence—Phenylpropanolamine—obesity	0.00135	0.00591	CcSEcCtD
Propantheline—Dizziness—Methamphetamine—obesity	0.00134	0.00586	CcSEcCtD
Propantheline—Insomnia—Phentermine—obesity	0.00132	0.00576	CcSEcCtD
Propantheline—Constipation—Phenylpropanolamine—obesity	0.0013	0.00569	CcSEcCtD
Propantheline—Dizziness—Benzphetamine—obesity	0.00129	0.00565	CcSEcCtD
Propantheline—Dry mouth—Diethylpropion—obesity	0.00129	0.00565	CcSEcCtD
Propantheline—Headache—Methamphetamine—obesity	0.00127	0.00555	CcSEcCtD
Propantheline—Mydriasis—Topiramate—obesity	0.00126	0.0055	CcSEcCtD
Propantheline—Feeling abnormal—Phenylpropanolamine—obesity	0.00125	0.00548	CcSEcCtD
Propantheline—Constipation—Phentermine—obesity	0.00124	0.00544	CcSEcCtD
Propantheline—Tachycardia—Diethylpropion—obesity	0.00124	0.0054	CcSEcCtD
Propantheline—Headache—Benzphetamine—obesity	0.00122	0.00535	CcSEcCtD
Propantheline—Confusional state—Cimetidine—obesity	0.00121	0.00531	CcSEcCtD
Propantheline—Anaphylactic shock—Cimetidine—obesity	0.0012	0.00527	CcSEcCtD
Propantheline—Thirst—Bupropion—obesity	0.0012	0.00525	CcSEcCtD
Propantheline—Abdominal distension—Orlistat—obesity	0.00118	0.00515	CcSEcCtD
Propantheline—Dizziness—Phendimetrazine—obesity	0.00118	0.00515	CcSEcCtD
Propantheline—Tachycardia—Cimetidine—obesity	0.00118	0.00514	CcSEcCtD
Propantheline—Nausea—Benzphetamine—obesity	0.00116	0.00507	CcSEcCtD
Propantheline—Urticaria—Phentermine—obesity	0.00116	0.00506	CcSEcCtD
Propantheline—Insomnia—Diethylpropion—obesity	0.00115	0.00501	CcSEcCtD
Propantheline—Abdominal distension—Sibutramine—obesity	0.00114	0.00498	CcSEcCtD
Propantheline—Dysphagia—Sibutramine—obesity	0.00113	0.00495	CcSEcCtD
Propantheline—Somnolence—Diethylpropion—obesity	0.00113	0.00492	CcSEcCtD
Propantheline—Hypersensitivity—Phenylpropanolamine—obesity	0.00112	0.0049	CcSEcCtD
Propantheline—Headache—Phendimetrazine—obesity	0.00112	0.00488	CcSEcCtD
Propantheline—Constipation—Diethylpropion—obesity	0.00108	0.00474	CcSEcCtD
Propantheline—Somnolence—Cimetidine—obesity	0.00107	0.00468	CcSEcCtD
Propantheline—Nausea—Phendimetrazine—obesity	0.00106	0.00463	CcSEcCtD
Propantheline—Asthenia—Phentermine—obesity	0.00104	0.00457	CcSEcCtD
Propantheline—Feeling abnormal—Diethylpropion—obesity	0.00104	0.00456	CcSEcCtD
Propantheline—Erectile dysfunction—Sibutramine—obesity	0.00104	0.00456	CcSEcCtD
Propantheline—Constipation—Cimetidine—obesity	0.00103	0.00451	CcSEcCtD
Propantheline—Urticaria—Diethylpropion—obesity	0.00101	0.0044	CcSEcCtD
Propantheline—Dizziness—Phenylpropanolamine—obesity	0.00101	0.0044	CcSEcCtD
Propantheline—Abdominal distension—Bupropion—obesity	0.000993	0.00434	CcSEcCtD
Propantheline—Feeling abnormal—Cimetidine—obesity	0.000993	0.00434	CcSEcCtD
Propantheline—Dysphagia—Bupropion—obesity	0.000987	0.00432	CcSEcCtD
Propantheline—Salivary hypersecretion—Topiramate—obesity	0.000973	0.00426	CcSEcCtD
Propantheline—Vomiting—Phenylpropanolamine—obesity	0.000967	0.00423	CcSEcCtD
Propantheline—Dizziness—Phentermine—obesity	0.000962	0.00421	CcSEcCtD
Propantheline—Rash—Phenylpropanolamine—obesity	0.000959	0.00419	CcSEcCtD
Propantheline—Dermatitis—Phenylpropanolamine—obesity	0.000958	0.00419	CcSEcCtD
Propantheline—Vomiting—Phentermine—obesity	0.000925	0.00405	CcSEcCtD
Propantheline—Rash—Phentermine—obesity	0.000918	0.00401	CcSEcCtD
Propantheline—Dermatitis—Phentermine—obesity	0.000917	0.00401	CcSEcCtD
Propantheline—Headache—Phentermine—obesity	0.000912	0.00399	CcSEcCtD
Propantheline—Erectile dysfunction—Bupropion—obesity	0.000909	0.00397	CcSEcCtD
Propantheline—Nausea—Phenylpropanolamine—obesity	0.000903	0.00395	CcSEcCtD
Propantheline—Hypersensitivity—Cimetidine—obesity	0.000888	0.00388	CcSEcCtD
Propantheline—Nausea—Phentermine—obesity	0.000865	0.00378	CcSEcCtD
Propantheline—Asthenia—Cimetidine—obesity	0.000864	0.00378	CcSEcCtD
Propantheline—Dizziness—Diethylpropion—obesity	0.000837	0.00366	CcSEcCtD
Propantheline—Vomiting—Diethylpropion—obesity	0.000805	0.00352	CcSEcCtD
Propantheline—Rash—Diethylpropion—obesity	0.000798	0.00349	CcSEcCtD
Propantheline—Dermatitis—Diethylpropion—obesity	0.000798	0.00349	CcSEcCtD
Propantheline—Dizziness—Cimetidine—obesity	0.000797	0.00348	CcSEcCtD
Propantheline—Headache—Diethylpropion—obesity	0.000793	0.00347	CcSEcCtD
Propantheline—Tension—Sibutramine—obesity	0.000774	0.00338	CcSEcCtD
Propantheline—Vision blurred—Orlistat—obesity	0.000768	0.00336	CcSEcCtD
Propantheline—Nervousness—Sibutramine—obesity	0.000766	0.00335	CcSEcCtD
Propantheline—Vomiting—Cimetidine—obesity	0.000766	0.00335	CcSEcCtD
Propantheline—Thirst—Topiramate—obesity	0.000764	0.00334	CcSEcCtD
Propantheline—Rash—Cimetidine—obesity	0.00076	0.00332	CcSEcCtD
Propantheline—Dermatitis—Cimetidine—obesity	0.000759	0.00332	CcSEcCtD
Propantheline—Headache—Cimetidine—obesity	0.000755	0.0033	CcSEcCtD
Propantheline—Nausea—Diethylpropion—obesity	0.000752	0.00329	CcSEcCtD
Propantheline—Vision blurred—Sibutramine—obesity	0.000743	0.00325	CcSEcCtD
Propantheline—Flushing—Bupropion—obesity	0.000733	0.00321	CcSEcCtD
Propantheline—Palpitations—Orlistat—obesity	0.00072	0.00315	CcSEcCtD
Propantheline—Nausea—Cimetidine—obesity	0.000716	0.00313	CcSEcCtD
Propantheline—Palpitations—Sibutramine—obesity	0.000697	0.00305	CcSEcCtD
Propantheline—Dry mouth—Orlistat—obesity	0.000679	0.00297	CcSEcCtD
Propantheline—Tension—Bupropion—obesity	0.000675	0.00295	CcSEcCtD
Propantheline—Nervousness—Bupropion—obesity	0.000668	0.00292	CcSEcCtD
Propantheline—Anaphylactic shock—Orlistat—obesity	0.000665	0.00291	CcSEcCtD
Propantheline—Dry mouth—Sibutramine—obesity	0.000657	0.00287	CcSEcCtD
Propantheline—Confusional state—Sibutramine—obesity	0.000649	0.00284	CcSEcCtD
Propantheline—Vision blurred—Bupropion—obesity	0.000648	0.00283	CcSEcCtD
Propantheline—Anaphylactic shock—Sibutramine—obesity	0.000644	0.00282	CcSEcCtD
Propantheline—Abdominal distension—Topiramate—obesity	0.000633	0.00277	CcSEcCtD
Propantheline—Dysphagia—Topiramate—obesity	0.000629	0.00275	CcSEcCtD
Propantheline—Tachycardia—Sibutramine—obesity	0.000628	0.00275	CcSEcCtD
Propantheline—Palpitations—Bupropion—obesity	0.000608	0.00266	CcSEcCtD
Propantheline—Insomnia—Orlistat—obesity	0.000602	0.00263	CcSEcCtD
Propantheline—Insomnia—Sibutramine—obesity	0.000582	0.00255	CcSEcCtD
Propantheline—Erectile dysfunction—Topiramate—obesity	0.000579	0.00253	CcSEcCtD
Propantheline—Dry mouth—Bupropion—obesity	0.000573	0.0025	CcSEcCtD
Propantheline—Somnolence—Sibutramine—obesity	0.000572	0.0025	CcSEcCtD
Propantheline—Confusional state—Bupropion—obesity	0.000566	0.00247	CcSEcCtD
Propantheline—Anaphylactic shock—Bupropion—obesity	0.000561	0.00245	CcSEcCtD
Propantheline—Constipation—Sibutramine—obesity	0.00055	0.00241	CcSEcCtD
Propantheline—Feeling abnormal—Orlistat—obesity	0.000548	0.0024	CcSEcCtD
Propantheline—Tachycardia—Bupropion—obesity	0.000548	0.0024	CcSEcCtD
Propantheline—Feeling abnormal—Sibutramine—obesity	0.00053	0.00232	CcSEcCtD
Propantheline—Urticaria—Orlistat—obesity	0.000528	0.00231	CcSEcCtD
Propantheline—Urticaria—Sibutramine—obesity	0.000511	0.00224	CcSEcCtD
Propantheline—Insomnia—Bupropion—obesity	0.000508	0.00222	CcSEcCtD
Propantheline—Somnolence—Bupropion—obesity	0.000499	0.00218	CcSEcCtD
Propantheline—Hypersensitivity—Orlistat—obesity	0.00049	0.00214	CcSEcCtD
Propantheline—Constipation—Bupropion—obesity	0.00048	0.0021	CcSEcCtD
Propantheline—Asthenia—Orlistat—obesity	0.000477	0.00209	CcSEcCtD
Propantheline—Hypersensitivity—Sibutramine—obesity	0.000474	0.00207	CcSEcCtD
Propantheline—Flushing—Topiramate—obesity	0.000467	0.00204	CcSEcCtD
Propantheline—Feeling abnormal—Bupropion—obesity	0.000462	0.00202	CcSEcCtD
Propantheline—Asthenia—Sibutramine—obesity	0.000462	0.00202	CcSEcCtD
Propantheline—Urticaria—Bupropion—obesity	0.000446	0.00195	CcSEcCtD
Propantheline—Dizziness—Orlistat—obesity	0.00044	0.00192	CcSEcCtD
Propantheline—Tension—Topiramate—obesity	0.00043	0.00188	CcSEcCtD
Propantheline—Dizziness—Sibutramine—obesity	0.000426	0.00186	CcSEcCtD
Propantheline—Nervousness—Topiramate—obesity	0.000425	0.00186	CcSEcCtD
Propantheline—Vomiting—Orlistat—obesity	0.000423	0.00185	CcSEcCtD
Propantheline—Rash—Orlistat—obesity	0.000419	0.00183	CcSEcCtD
Propantheline—Dermatitis—Orlistat—obesity	0.000419	0.00183	CcSEcCtD
Propantheline—Headache—Orlistat—obesity	0.000417	0.00182	CcSEcCtD
Propantheline—Hypersensitivity—Bupropion—obesity	0.000413	0.00181	CcSEcCtD
Propantheline—Vision blurred—Topiramate—obesity	0.000413	0.00181	CcSEcCtD
Propantheline—Vomiting—Sibutramine—obesity	0.000409	0.00179	CcSEcCtD
Propantheline—Rash—Sibutramine—obesity	0.000406	0.00178	CcSEcCtD
Propantheline—Dermatitis—Sibutramine—obesity	0.000405	0.00177	CcSEcCtD
Propantheline—Headache—Sibutramine—obesity	0.000403	0.00176	CcSEcCtD
Propantheline—Asthenia—Bupropion—obesity	0.000403	0.00176	CcSEcCtD
Propantheline—Nausea—Orlistat—obesity	0.000395	0.00173	CcSEcCtD
Propantheline—Palpitations—Topiramate—obesity	0.000387	0.00169	CcSEcCtD
Propantheline—Nausea—Sibutramine—obesity	0.000382	0.00167	CcSEcCtD
Propantheline—Dizziness—Bupropion—obesity	0.000371	0.00162	CcSEcCtD
Propantheline—Dry mouth—Topiramate—obesity	0.000365	0.0016	CcSEcCtD
Propantheline—Confusional state—Topiramate—obesity	0.000361	0.00158	CcSEcCtD
Propantheline—Vomiting—Bupropion—obesity	0.000357	0.00156	CcSEcCtD
Propantheline—Rash—Bupropion—obesity	0.000354	0.00155	CcSEcCtD
Propantheline—Dermatitis—Bupropion—obesity	0.000354	0.00155	CcSEcCtD
Propantheline—Headache—Bupropion—obesity	0.000352	0.00154	CcSEcCtD
Propantheline—Tachycardia—Topiramate—obesity	0.000349	0.00153	CcSEcCtD
Propantheline—Nausea—Bupropion—obesity	0.000333	0.00146	CcSEcCtD
Propantheline—Insomnia—Topiramate—obesity	0.000323	0.00141	CcSEcCtD
Propantheline—Somnolence—Topiramate—obesity	0.000318	0.00139	CcSEcCtD
Propantheline—Constipation—Topiramate—obesity	0.000306	0.00134	CcSEcCtD
Propantheline—Feeling abnormal—Topiramate—obesity	0.000295	0.00129	CcSEcCtD
Propantheline—Urticaria—Topiramate—obesity	0.000284	0.00124	CcSEcCtD
Propantheline—Hypersensitivity—Topiramate—obesity	0.000263	0.00115	CcSEcCtD
Propantheline—Asthenia—Topiramate—obesity	0.000257	0.00112	CcSEcCtD
Propantheline—Dizziness—Topiramate—obesity	0.000236	0.00103	CcSEcCtD
Propantheline—Vomiting—Topiramate—obesity	0.000227	0.000994	CcSEcCtD
Propantheline—Rash—Topiramate—obesity	0.000225	0.000986	CcSEcCtD
Propantheline—Dermatitis—Topiramate—obesity	0.000225	0.000985	CcSEcCtD
Propantheline—Headache—Topiramate—obesity	0.000224	0.00098	CcSEcCtD
Propantheline—Nausea—Topiramate—obesity	0.000212	0.000929	CcSEcCtD
Propantheline—CHRM2—cardiovascular system—obesity	0.000211	0.0791	CbGeAlD
Propantheline—CHRM1—cardiovascular system—obesity	0.000192	0.072	CbGeAlD
Propantheline—CHRM3—adipose tissue—obesity	0.000152	0.0568	CbGeAlD
Propantheline—CHRM2—endocrine gland—obesity	0.000145	0.0543	CbGeAlD
Propantheline—CHRM3—digestive system—obesity	0.000143	0.0535	CbGeAlD
Propantheline—CHRM1—endocrine gland—obesity	0.000132	0.0494	CbGeAlD
Propantheline—CHRM3—endocrine gland—obesity	0.000118	0.0442	CbGeAlD
Propantheline—CHRM3—Signaling Pathways—CNR1—obesity	1.88e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GNB3—obesity	1.87e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARGC1A—obesity	1.87e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—HMOX1—obesity	1.87e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CNR1—obesity	1.86e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TCF7L2—obesity	1.86e-05	0.000131	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TCF7L2—obesity	1.85e-05	0.000131	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT2—obesity	1.85e-05	0.000131	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—DRD2—obesity	1.84e-05	0.000131	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT2—obesity	1.84e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—DRD2—obesity	1.84e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CG—obesity	1.83e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TCF7L2—obesity	1.83e-05	0.00013	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CG—obesity	1.83e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GNAS—obesity	1.83e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTPN1—obesity	1.82e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GCG—obesity	1.82e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT2—obesity	1.82e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—DRD2—obesity	1.82e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTPN1—obesity	1.82e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GCG—obesity	1.82e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CG—obesity	1.81e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GCG—obesity	1.8e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTPN1—obesity	1.8e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOB—obesity	1.79e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CD—obesity	1.77e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CD—obesity	1.77e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CD—obesity	1.75e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—POMC—obesity	1.75e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRL—obesity	1.74e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—POMC—obesity	1.74e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRL—obesity	1.74e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—POMC—obesity	1.72e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRL—obesity	1.72e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STK11—obesity	1.72e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STK11—obesity	1.71e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CCL2—obesity	1.71e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—LPL—obesity	1.71e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CCL2—obesity	1.7e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLG—obesity	1.7e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—RHOA—obesity	1.69e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STK11—obesity	1.69e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLG—obesity	1.69e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—RHOA—obesity	1.69e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CCL2—obesity	1.69e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT2—obesity	1.68e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3R1—obesity	1.68e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLG—obesity	1.67e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT2—obesity	1.67e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—RHOA—obesity	1.67e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3R1—obesity	1.67e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GPX1—obesity	1.67e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT2—obesity	1.66e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FOXO3—obesity	1.66e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3R1—obesity	1.65e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADRB2—obesity	1.65e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FOXO3—obesity	1.65e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADRB2—obesity	1.65e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FOXO3—obesity	1.63e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADRB2—obesity	1.63e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SOCS1—obesity	1.63e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CD36—obesity	1.62e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SOCS1—obesity	1.62e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CD—obesity	1.61e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CD—obesity	1.61e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SOCS3—obesity	1.61e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SOCS1—obesity	1.61e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SOCS3—obesity	1.6e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CD—obesity	1.59e-05	0.000113	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SOCS3—obesity	1.59e-05	0.000112	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GNB3—obesity	1.57e-05	0.000111	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GNB3—obesity	1.57e-05	0.000111	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GNB3—obesity	1.55e-05	0.00011	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—TYK2—obesity	1.55e-05	0.00011	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CB—obesity	1.55e-05	0.00011	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—TYK2—obesity	1.55e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF2—obesity	1.54e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CB—obesity	1.54e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF2—obesity	1.54e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—RHOA—obesity	1.54e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—MTHFR—obesity	1.54e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—RHOA—obesity	1.53e-05	0.000109	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GNAS—obesity	1.53e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—TYK2—obesity	1.53e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CB—obesity	1.53e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GNAS—obesity	1.53e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF2—obesity	1.52e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3R1—obesity	1.52e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—RHOA—obesity	1.52e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3R1—obesity	1.52e-05	0.000107	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GNAS—obesity	1.51e-05	0.000107	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARA—obesity	1.51e-05	0.000107	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3R1—obesity	1.5e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOB—obesity	1.5e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOB—obesity	1.49e-05	0.000106	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOB—obesity	1.48e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL5—obesity	1.46e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AGT—obesity	1.46e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL5—obesity	1.46e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL5—obesity	1.45e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LPL—obesity	1.43e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOE—obesity	1.43e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LPL—obesity	1.43e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FOXO1—obesity	1.42e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RPS6KB1—obesity	1.42e-05	0.000101	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CAV1—obesity	1.42e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FOXO1—obesity	1.42e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RPS6KB1—obesity	1.41e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOA1—obesity	1.41e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LPL—obesity	1.41e-05	0.0001	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CB—obesity	1.4e-05	9.95e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FOXO1—obesity	1.4e-05	9.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RPS6KB1—obesity	1.4e-05	9.92e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CB—obesity	1.4e-05	9.92e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CB—obesity	1.39e-05	9.82e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCD—obesity	1.32e-05	9.34e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCD—obesity	1.31e-05	9.31e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCD—obesity	1.3e-05	9.22e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CG—obesity	1.29e-05	9.15e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HTR2A—obesity	1.29e-05	9.14e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—C3—obesity	1.29e-05	9.13e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HTR2A—obesity	1.29e-05	9.11e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—C3—obesity	1.29e-05	9.1e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HTR2A—obesity	1.27e-05	9.03e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—C3—obesity	1.27e-05	9.01e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARG—obesity	1.25e-05	8.83e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—POMC—obesity	1.23e-05	8.71e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IRS2—obesity	1.23e-05	8.69e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGT—obesity	1.22e-05	8.68e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IRS2—obesity	1.22e-05	8.66e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—INS—obesity	1.22e-05	8.66e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGT—obesity	1.22e-05	8.65e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IRS2—obesity	1.21e-05	8.57e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGT—obesity	1.21e-05	8.56e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LEP—obesity	1.2e-05	8.5e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOE—obesity	1.2e-05	8.5e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LEP—obesity	1.2e-05	8.47e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOE—obesity	1.2e-05	8.47e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CAV1—obesity	1.19e-05	8.42e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOA1—obesity	1.19e-05	8.4e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CAV1—obesity	1.19e-05	8.4e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LEP—obesity	1.18e-05	8.39e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOE—obesity	1.18e-05	8.39e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOA1—obesity	1.18e-05	8.38e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CAV1—obesity	1.17e-05	8.31e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOA1—obesity	1.17e-05	8.3e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ESR1—obesity	1.15e-05	8.12e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ESR1—obesity	1.14e-05	8.09e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CD—obesity	1.14e-05	8.04e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCB—obesity	1.13e-05	8.02e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—F2—obesity	1.13e-05	8.02e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ESR1—obesity	1.13e-05	8.01e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—F2—obesity	1.13e-05	7.99e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCB—obesity	1.13e-05	7.99e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ALB—obesity	1.12e-05	7.94e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—BAD—obesity	1.12e-05	7.92e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—F2—obesity	1.12e-05	7.91e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCB—obesity	1.12e-05	7.91e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—BAD—obesity	1.11e-05	7.9e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—BAD—obesity	1.1e-05	7.82e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CG—obesity	1.08e-05	7.67e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CG—obesity	1.08e-05	7.65e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—NOS3—obesity	1.07e-05	7.59e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3R1—obesity	1.07e-05	7.59e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IRS1—obesity	1.07e-05	7.58e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CG—obesity	1.07e-05	7.57e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IRS1—obesity	1.07e-05	7.56e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IRS1—obesity	1.06e-05	7.49e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—POMC—obesity	1.03e-05	7.3e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—POMC—obesity	1.03e-05	7.28e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—INS—obesity	1.03e-05	7.26e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—INS—obesity	1.02e-05	7.24e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—POMC—obesity	1.02e-05	7.21e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—INS—obesity	1.01e-05	7.17e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL2—obesity	1.01e-05	7.15e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL2—obesity	1.01e-05	7.12e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL2—obesity	9.96e-06	7.05e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1—obesity	9.92e-06	7.02e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT2—obesity	9.91e-06	7.02e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CB—obesity	9.89e-06	7.01e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1—obesity	9.89e-06	7e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT2—obesity	9.88e-06	7e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—obesity	9.8e-06	6.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1—obesity	9.79e-06	6.93e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT2—obesity	9.78e-06	6.93e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CD—obesity	9.52e-06	6.74e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CD—obesity	9.49e-06	6.72e-05	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CA—obesity	9.43e-06	6.68e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SERPINE1—obesity	9.42e-06	6.67e-05	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CA—obesity	9.4e-06	6.66e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CD—obesity	9.4e-06	6.66e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SERPINE1—obesity	9.39e-06	6.65e-05	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CA—obesity	9.31e-06	6.59e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SERPINE1—obesity	9.3e-06	6.58e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TYK2—obesity	9.16e-06	6.49e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TYK2—obesity	9.13e-06	6.47e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RHOA—obesity	9.08e-06	6.43e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RHOA—obesity	9.06e-06	6.41e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TYK2—obesity	9.04e-06	6.4e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOS3—obesity	8.99e-06	6.37e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3R1—obesity	8.99e-06	6.37e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RHOA—obesity	8.97e-06	6.35e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOS3—obesity	8.96e-06	6.35e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3R1—obesity	8.96e-06	6.35e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOS3—obesity	8.88e-06	6.29e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3R1—obesity	8.88e-06	6.29e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CA—obesity	8.56e-06	6.07e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CA—obesity	8.54e-06	6.05e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CA—obesity	8.45e-06	5.99e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MTOR—obesity	8.3e-06	5.88e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CB—obesity	8.3e-06	5.88e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CB—obesity	8.27e-06	5.86e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MTOR—obesity	8.27e-06	5.86e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MTOR—obesity	8.19e-06	5.8e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CB—obesity	8.19e-06	5.8e-05	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—obesity	7.7e-06	5.46e-05	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—obesity	7.68e-06	5.44e-05	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—obesity	7.61e-06	5.39e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6—obesity	7.58e-06	5.37e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6—obesity	7.56e-06	5.35e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6—obesity	7.49e-06	5.3e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—obesity	7.21e-06	5.11e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—obesity	7.19e-06	5.09e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—obesity	7.12e-06	5.04e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK8—obesity	7.02e-06	4.97e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—obesity	7e-06	4.96e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK8—obesity	6.99e-06	4.95e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—obesity	6.97e-06	4.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK8—obesity	6.93e-06	4.91e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—obesity	6.91e-06	4.89e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT3—obesity	6.41e-06	4.54e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT3—obesity	6.39e-06	4.53e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT3—obesity	6.33e-06	4.48e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CA—obesity	6.03e-06	4.27e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MYC—obesity	5.96e-06	4.22e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFB1—obesity	5.95e-06	4.21e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MYC—obesity	5.94e-06	4.21e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFB1—obesity	5.93e-06	4.2e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MYC—obesity	5.88e-06	4.17e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFB1—obesity	5.87e-06	4.16e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CA—obesity	5.06e-06	3.58e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CA—obesity	5.04e-06	3.57e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CA—obesity	4.99e-06	3.54e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—obesity	4.93e-06	3.49e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6—obesity	4.48e-06	3.17e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6—obesity	4.47e-06	3.16e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6—obesity	4.42e-06	3.13e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—obesity	4.13e-06	2.93e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—obesity	4.12e-06	2.92e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—obesity	4.08e-06	2.89e-05	CbGpPWpGaD
